Your browser doesn't support javascript.
loading
Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.
Glavaski-Joksimovic, Aleksandra; Virag, Tamas; Mangatu, Thomas A; McGrogan, Michael; Wang, Xue Song; Bohn, Martha C.
Affiliation
  • Glavaski-Joksimovic A; Department of Pediatrics, Neurobiology Program, Children's Memorial Research Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60614, USA.
J Neurosci Res ; 88(12): 2669-81, 2010 Sep.
Article in En | MEDLINE | ID: mdl-20544825
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Recovery of Function / Parkinsonian Disorders / Mesenchymal Stem Cell Transplantation / Glial Cell Line-Derived Neurotrophic Factor / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Adult / Animals / Humans / Male Language: En Journal: J Neurosci Res Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Transplantation / Recovery of Function / Parkinsonian Disorders / Mesenchymal Stem Cell Transplantation / Glial Cell Line-Derived Neurotrophic Factor / Mesenchymal Stem Cells Type of study: Prognostic_studies Limits: Adult / Animals / Humans / Male Language: En Journal: J Neurosci Res Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States